Seite - 82 - in Cancer Nanotheranostics - What Have We Learnd So Far?
Bild der Seite - 82 -
Text der Seite - 82 -
Conniotet al. Nanocarriers for immunecell targetingand tracking
FIGURE6 |Ligand-cell interactionandNP internalization.NPscanbe
functionalizedwithdifferent ligands to increasecell targetingandNP
internalization. (A)FunctionalizationofNPswithantibodiesallows the
targetingofantigensexclusivelyexpressedoroverexpressedby target cells
(e.g., anti-CD205antibody to targetCD205onDCsoranti-HER2antibody to
targetHER2onbreast cancercells). (B) Inorder to targetDCs,NPscanbe
functionalizedwithmolecules thatmimicPAMPs,normally carbohydrates,
nucleic acidsor lipids,whichare recognizedbyPRRsexpressedbyDCs.For
instance,mannoseor fucose residuesare recognizedby themannose
receptors—aC-lectin receptor.Bacterial lipopolysaccharideorflagellin target TLR4andTLR5onDCs, respectively. (C)Cell-penetratingpeptidesaresmall
aminoacidsequencesnormallyusedbyvirusesorbacteria to facilitate
cellular invasionby thosepathogensandcanbeused to increase the
internalizationofNPs.FunctionalizedNPssee their internalizationby target
cells increasedessentiallyby twomechanisms: inductionofendocytosis
upon ligand-receptorbinding,whichhappens toNPs functionalizedwith
ligandssuchasantibodies,PAMPsorsomepenetratingpeptides that induce
receptor-mediatedendocytosis (e.g., integrins)or (D) throughdirect cell
penetrationacross theplasmamembrane (e.g., antimicrobial peptidesor
histidine-richpeptides) (E)orboth (e.g.,HIVTATpeptide).
indirect mechanisms involving TLR-activated DCs (Silva et al.,
2013).C-type lectin receptors (CLRs) belong to another class of
PRRsexpressedbyAPCs.This receptor family is characterizedby
thepresenceofdomains thatbind to carbohydrates (VanKooyk,
2008). CLRs are specific receptors particularly engaged in the
internalization of antigens. CLRs enable the intracellular uptake
andprocessingofantigens,aswellas influencetheircytosolic fate
and the loading onMHCclass I and II (Unger andVanKooyk,
2011).
Regarding the involvement of PRRs in several strategic
immunepathways, thedesignofnano-basedsystemsfor immune
cell targeting can be extremely interesting. Not only because a
morespecificdeliverycanbeachieved,butalsobecausethecellu-
lar internalizationof the targetednanosystemcanbemodulated
and potentiated. Additionally, the attachment of PRRs ligands on the surface of nanocarriers may boost their immunogenic-
ity,whichcanbeanoutstanding strategy for thedevelopmentof
vaccines, since it allows the incorporationof an antigen and the
“danger signal” in thesameplatform(Silvaetal., 2013).
NANOCARRIERSFORIMAGINGAPPROACHES
The importance of a deeper knowledge of the dynamic cancer
immunological processes has long been realized. The study of
theseprocesses in vivo,with living cells and thewholeorganism,
is essential to answer this issuemore accurately. Cancer disease
processeswill bebetterunderstoodand thus improved therapies
can surely bedeveloped. For the visualizationof these biological
dynamic processes in vivo, methods have to provide a real-time
in situ fast response, as well as be non-invasive and with high
sensitivityandstability (Wangetal., 2013b).
www.frontiersin.org November2014 |Volume2 |Article105 | 82
Cancer Nanotheranostics
What Have We Learnd So Far?
- Titel
- Cancer Nanotheranostics
- Untertitel
- What Have We Learnd So Far?
- Autoren
- João Conde
- Pedro Viana Baptista
- Jesús M. De La Fuente
- Furong Tian
- Herausgeber
- Frontiers in Chemistry
- Datum
- 2016
- Sprache
- englisch
- Lizenz
- CC BY 4.0
- ISBN
- 978-2-88919-776-7
- Abmessungen
- 21.0 x 27.7 cm
- Seiten
- 132
- Schlagwörter
- Nanomedicine, Nanoparticles, nanomaterials, Cancer, heranostics, Immunotherapy, bioimaging, Drug delivery, Gene Therapy, Phototherapy
- Kategorien
- Naturwissenschaften Chemie